<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://publications.europa.eu/resource/schema/ted/R2.0.9/publication" xmlns:n2021="http://publications.europa.eu/resource/schema/ted/2021/nuts" xsi:schemaLocation="http://publications.europa.eu/resource/schema/ted/R2.0.9/publication TED_EXPORT.xsd" VERSION="R2.0.9.S05.E01" DOC_ID="625874-2021" EDITION="2021237"><TECHNICAL_SECTION><RECEPTION_ID>21-645434-001</RECEPTION_ID><DELETION_DATE>20220312</DELETION_DATE><FORM_LG_LIST>EN </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="https://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="https://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="https://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="https://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="https://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>237</NO_OJ><DATE_PUB>20211207</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2021/S 237-625874</NO_DOC_OJS><URI_LIST><URI_DOC LG="EN">https://ted.europa.eu/udl?uri=TED:NOTICE:625874-2021:TEXT:EN:HTML</URI_DOC></URI_LIST><LG_ORIG>EN</LG_ORIG><ISO_COUNTRY VALUE="IS"/><IA_URL_GENERAL>https://www.landspitali.is/um-landspitala/languages/landspitali-the-national-university-hospital-of-iceland/</IA_URL_GENERAL><ORIGINAL_CPV CODE="33600000">Pharmaceutical products</ORIGINAL_CPV><n2021:PERFORMANCE_NUTS CODE="IS00">Ísland</n2021:PERFORMANCE_NUTS><n2021:CA_CE_NUTS CODE="IS0">Ísland</n2021:CA_CE_NUTS><VALUES><VALUE_RANGE TYPE="PROCUREMENT_TOTAL" CURRENCY="ISK"><LOW>270000000.00</LOW><HIGH>310000000.00</HIGH></VALUE_RANGE></VALUES></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20211202</DS_DATE_DISPATCH><AA_AUTHORITY_TYPE CODE="4">Utilities entity</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="V">Voluntary ex ante transparency notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE><PR_PROC CODE="T">Negotiated without a prior call for competition</PR_PROC><RP_REGULATION CODE="B">European Economic Area (EEA), with participation by GPA countries</RP_REGULATION><TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID><AC_AWARD_CRIT CODE="Z">Not specified</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="8">Other</MA_MAIN_ACTIVITIES><HEADING>03F15</HEADING><INITIATOR>03</INITIATOR></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Исландия</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Фармацевтични продукти</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Island</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Léčivé přípravky a zdravotnické prostředky</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Island</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Lægemidler</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>Island</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Arzneimittel</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Ισλανδία</TI_CY><TI_TOWN>Ρέικιαβικ</TI_TOWN><TI_TEXT><P>Φαρμακευτικά προϊόντα</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>Iceland</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Pharmaceutical products</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>Islandia</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Productos farmacéuticos</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Island</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Ravimid</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Islanti</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Farmaseuttiset tuotteet</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>Islande</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Produits pharmaceutiques</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Íoslainn, an</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Pharmaceutical products</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Island</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Farmaceutski proizvodi</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Izland</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Gyógyszerészeti termékek</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Islanda</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Prodotti farmaceutici</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Islandija</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Farmacijos produktai</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Islande</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Farmācijas izstrādājumi</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>l-Islanda</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Prodotti farmaċewtiċi</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>Ĳsland</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Farmaceutische producten</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Islandia</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Produkty farmaceutyczne</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>Islândia</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Produtos farmacêuticos</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>Islanda</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Produse farmaceutice</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Island</TI_CY><TI_TOWN>Reykjavík</TI_TOWN><TI_TEXT><P>Farmaceutické výrobky</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Islandija</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Farmacevtski proizvodi</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Island</TI_CY><TI_TOWN>Reykjavik</TI_TOWN><TI_TEXT><P>Läkemedel</P></TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="EN">Landspitali - The National University Hospital of Iceland</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><F15_2014 CATEGORY="ORIGINAL" FORM="F15" LG="EN"><LEGAL_BASIS VALUE="32014L0025"/><CONTRACTING_BODY><ADDRESS_CONTRACTING_BODY><OFFICIALNAME>Landspitali - The National University Hospital of Iceland</OFFICIALNAME><NATIONALID>500300-2130</NATIONALID><TOWN>Reykjavík</TOWN><COUNTRY VALUE="IS"/><CONTACT_POINT>Hulda Harðardóttir</CONTACT_POINT><PHONE>+354 5431512</PHONE><E_MAIL>huldahar@landspitali.is</E_MAIL><n2021:NUTS CODE="IS0"/><URL_GENERAL>https://www.landspitali.is/um-landspitala/languages/landspitali-the-national-university-hospital-of-iceland/</URL_GENERAL></ADDRESS_CONTRACTING_BODY><CE_ACTIVITY_OTHER>Health sector</CE_ACTIVITY_OTHER></CONTRACTING_BODY><OBJECT_CONTRACT><TITLE><P>Pharmaceutical products</P></TITLE><CPV_MAIN><CPV_CODE CODE="33600000"/></CPV_MAIN><TYPE_CONTRACT CTYPE="SUPPLIES"/><SHORT_DESCR><P>The reservation of supplying specified medicine in ATC categories; L01XX46, L01XC19, L04AA33, N07BC01, L01BC59, R07AX30 at Landspítali site for 12 months, The contract(s) is for the benefit of the contracting authority necessary for the delivery of medicinal goods of healthcare and health related services in Iceland. </P></SHORT_DESCR><VAL_RANGE_TOTAL CURRENCY="ISK" PUBLICATION="YES"><LOW>270000000.00</LOW><HIGH>310000000.00</HIGH></VAL_RANGE_TOTAL><NO_LOT_DIVISION/><OBJECT_DESCR ITEM="1"><n2021:NUTS CODE="IS00"/><MAIN_SITE><P>at Landspítali site</P></MAIN_SITE><SHORT_DESCR><P>Award of a contract without prior publication of a call for competition in the Official Journal of the European. Negotiated procedure without prior publication (in accordance with Article 32 of Directive 2014/24/EU) on basis of insufficient competition and lack of supply as no tenders or requests to participate were submitted in response to open procurement procedure</P></SHORT_DESCR><NO_OPTIONS/><NO_EU_PROGR_RELATED/></OBJECT_DESCR></OBJECT_CONTRACT><PROCEDURE><DIRECTIVE_2014_25_EU><PT_NEGOTIATED_WITHOUT_PUBLICATION><D_ACCORDANCE_ARTICLE><D_NO_TENDERS_REQUESTS/><D_TECHNICAL/></D_ACCORDANCE_ARTICLE><D_JUSTIFICATION><P>Award of a contract without prior publication of a call for competition in the Official Journal of the European. Negotiated procedure without prior publication (in accordance with Article 32 of Directive 2014/24/EU) on basis of insufficient competition and lack of supply as no tenders or requests to participate were submitted in response to open procurement procedure</P></D_JUSTIFICATION></PT_NEGOTIATED_WITHOUT_PUBLICATION></DIRECTIVE_2014_25_EU><CONTRACT_COVERED_GPA/></PROCEDURE><AWARD_CONTRACT ITEM="1"><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-06-01</DATE_CONCLUSION_CONTRACT></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="2"><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-06-01</DATE_CONCLUSION_CONTRACT></AWARDED_CONTRACT></AWARD_CONTRACT><AWARD_CONTRACT ITEM="3"><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2020-06-01</DATE_CONCLUSION_CONTRACT></AWARDED_CONTRACT></AWARD_CONTRACT><COMPLEMENTARY_INFO><ADDRESS_REVIEW_BODY><OFFICIALNAME>Kærunefnd útboðsmála</OFFICIALNAME><TOWN>Reykjavík</TOWN><COUNTRY VALUE="IS"/></ADDRESS_REVIEW_BODY><DATE_DISPATCH_NOTICE>2021-12-02</DATE_DISPATCH_NOTICE></COMPLEMENTARY_INFO></F15_2014></FORM_SECTION></TED_EXPORT>